Skip to main content

Table 5 Infectious outcomes of the intent to treat and per-protocol study populations stratified by ciprofloxacin susceptibility status

From: Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial

 

Ciprofloxacin-susceptible

Ciprofloxacin-resistant

All

P value

Intent to Treat

N (%) = 430 (84.3)

N (%) = 80 (15.7)

N (%) = 510

 

Any infection n, (%), 95% CI

6, (1.4), 0.5–3.8

3, (3.8), 0.8–10.6

9 (1.8) 0.8–3.3

0.314

 No/Yes (n/n; %/%)

424/6 (98.6/1.4)

77/3 (96.2/3.8)

501/9 (98.2/1.8)

 

 Type of infection; n (%)

   

0.277

  None

424 (98.6)

77 (96.2)

501 (98.2)

 

  Uncomplicated UTI

3 (0.7)

2 (2.5)

5 (1.0)

 

  Complicated UTI

1 (0.2)

0 (0.0)

1 (0.2)

 

  Urosepsis

2 (0.5)

1 (1.3)

3 (0.6)

 

Per Protocol

N = 406 (83.9%)

N = 78 (16.1%)

N = 484

 

Any infection n, (%), 95% CI

6, (1.5), 0.5–3.0

3, (3.9), 0.8–10.8)

9, (1.9), 0.9–3.5

0.337

 No/Yes (n/n; %/%)

400/6 (98.5/1.5)

75/3 (96.1/3.9)

475/9 (98.1/1.9)

 

 Type of infection; n (%)

   

0.288

  None

400 (98.5)

75 (96.1)

475 (98.1)

 

  Uncomplicated UTI

3 (0.7)

2 (2.6)

5 (1.0)

 

  Complicated UTI

1 (0.2)

0 (0.0)

1 (0.2)

 

  Urosepsis

2 (0.5)

1 (1.3)

3 (0.6)

 
  1. Abbreviations: UTI urinary tract infection